CCL INDUSTRIES INC - CL B (CCL-B.CA) Fundamental Analysis & Valuation

TSX:CCL-B • CA1249003098

Current stock price

87.25 CAD
-0.15 (-0.17%)
Last:

This CCL-B.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CCL-B.CA Profitability Analysis

1.1 Basic Checks

  • CCL-B had positive earnings in the past year.
  • In the past year CCL-B had a positive cash flow from operations.
  • Each year in the past 5 years CCL-B has been profitable.
  • CCL-B had a positive operating cash flow in each of the past 5 years.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • CCL-B has a Return On Assets of 7.94%. This is amongst the best in the industry. CCL-B outperforms 85.71% of its industry peers.
  • Looking at the Return On Equity, with a value of 14.23%, CCL-B belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CCL-B has a better Return On Invested Capital (11.25%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CCL-B is above the industry average of 7.99%.
  • The 3 year average ROIC (10.12%) for CCL-B is below the current ROIC(11.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.94%
ROE 14.23%
ROIC 11.25%
ROA(3y)7.48%
ROA(5y)7.5%
ROE(3y)13.89%
ROE(5y)14.45%
ROIC(3y)10.12%
ROIC(5y)9.94%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CCL-B (10.47%) is better than 85.71% of its industry peers.
  • In the last couple of years the Profit Margin of CCL-B has remained more or less at the same level.
  • With an excellent Operating Margin value of 15.10%, CCL-B belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • CCL-B's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 29.96%, CCL-B is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • CCL-B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.1%
PM (TTM) 10.47%
GM 29.96%
OM growth 3Y3.77%
OM growth 5Y0.38%
PM growth 3Y2.38%
PM growth 5Y0.71%
GM growth 3Y3.69%
GM growth 5Y0.9%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CCL-B.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL-B is still creating some value.
  • CCL-B has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CCL-B has been reduced compared to 5 years ago.
  • The debt/assets ratio for CCL-B has been reduced compared to a year ago.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.94 indicates that CCL-B is not in any danger for bankruptcy at the moment.
  • CCL-B's Altman-Z score of 3.94 is amongst the best of the industry. CCL-B outperforms 85.71% of its industry peers.
  • The Debt to FCF ratio of CCL-B is 2.62, which is a good value as it means it would take CCL-B, 2.62 years of fcf income to pay off all of its debts.
  • CCL-B's Debt to FCF ratio of 2.62 is fine compared to the rest of the industry. CCL-B outperforms 71.43% of its industry peers.
  • CCL-B has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • CCL-B has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: CCL-B outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.62
Altman-Z 3.94
ROIC/WACC1.56
WACC7.22%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • CCL-B has a Current Ratio of 1.42. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CCL-B (1.42) is worse than 85.71% of its industry peers.
  • CCL-B has a Quick Ratio of 1.07. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.07, CCL-B is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • CCL-B does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.07
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CCL-B.CA Growth Analysis

3.1 Past

  • CCL-B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.77%.
  • Measured over the past years, CCL-B shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.28% on average per year.
  • The Revenue has been growing slightly by 5.78% in the past year.
  • The Revenue has been growing slightly by 7.89% on average over the past years.
EPS 1Y (TTM)-2.77%
EPS 3Y8.99%
EPS 5Y8.28%
EPS Q2Q%-1.98%
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.29%
Revenue growth 5Y7.89%
Sales Q2Q%3.51%

3.2 Future

  • Based on estimates for the next years, CCL-B will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.00% on average per year.
  • CCL-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y10.99%
EPS Next 2Y9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.13%
Revenue Next 2Y4.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. CCL-B.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.09, which indicates a rather expensive current valuation of CCL-B.
  • Based on the Price/Earnings ratio, CCL-B is valued a bit more expensive than 71.43% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CCL-B to the average of the S&P500 Index (27.42), we can say CCL-B is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 17.20, which indicates a rather expensive current valuation of CCL-B.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 71.43% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CCL-B to the average of the S&P500 Index (22.24), we can say CCL-B is valued slightly cheaper.
Industry RankSector Rank
PE 19.09
Fwd PE 17.2
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CCL-B's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CCL-B is more expensive than 71.43% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CCL-B.
Industry RankSector Rank
P/FCF 17.45
EV/EBITDA 10.08
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CCL-B has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.74
PEG (5Y)2.31
EPS Next 2Y9%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CCL-B.CA Dividend Analysis

5.1 Amount

  • CCL-B has a Yearly Dividend Yield of 1.67%.
  • CCL-B's Dividend Yield is comparable with the industry average which is at 6.44.
  • Compared to an average S&P500 Dividend Yield of 1.81, CCL-B has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • On average, the dividend of CCL-B grows each year by 12.18%, which is quite nice.
  • CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
  • CCL-B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.18%
Div Incr Years24
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 27.88% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
  • The dividend of CCL-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.88%
EPS Next 2Y9%
EPS Next 3YN/A
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CCL-B.CA Fundamentals: All Metrics, Ratios and Statistics

CCL INDUSTRIES INC - CL B

TSX:CCL-B (4/24/2026, 7:00:00 PM)

87.25

-0.15 (-0.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-25
Earnings (Next)05-13
Inst Owners38.34%
Inst Owner ChangeN/A
Ins Owners1.95%
Ins Owner ChangeN/A
Market Cap15.07B
Revenue(TTM)7.66B
Net Income(TTM)802.40M
Analysts82.11
Price Target103.12 (18.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend1.28
Dividend Growth(5Y)12.18%
DP27.88%
Div Incr Years24
Div Non Decr Years34
Ex-Date03-17
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.08%
Min EPS beat(2)-12.42%
Max EPS beat(2)0.26%
EPS beat(4)3
Avg EPS beat(4)-1.45%
Min EPS beat(4)-12.42%
Max EPS beat(4)4.21%
EPS beat(8)5
Avg EPS beat(8)4.61%
EPS beat(12)6
Avg EPS beat(12)1.41%
EPS beat(16)8
Avg EPS beat(16)1.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.77%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.56%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-0.46%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)1
Avg Revenue beat(12)-1.79%
Revenue beat(16)3
Avg Revenue beat(16)-1.61%
PT rev (1m)2.35%
PT rev (3m)3.91%
EPS NQ rev (1m)0.24%
EPS NQ rev (3m)-3.2%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 19.09
Fwd PE 17.2
P/S 1.97
P/FCF 17.45
P/OCF 11.55
P/B 2.67
P/tB 7.52
EV/EBITDA 10.08
EPS(TTM)4.57
EY5.24%
EPS(NY)5.07
Fwd EY5.81%
FCF(TTM)5
FCFY5.73%
OCF(TTM)7.55
OCFY8.66%
SpS44.38
BVpS32.67
TBVpS11.6
PEG (NY)1.74
PEG (5Y)2.31
Graham Number57.9557 (-33.58%)
Profitability
Industry RankSector Rank
ROA 7.94%
ROE 14.23%
ROCE 14.79%
ROIC 11.25%
ROICexc 12.9%
ROICexgc 27.61%
OM 15.1%
PM (TTM) 10.47%
GM 29.96%
FCFM 11.26%
ROA(3y)7.48%
ROA(5y)7.5%
ROE(3y)13.89%
ROE(5y)14.45%
ROIC(3y)10.12%
ROIC(5y)9.94%
ROICexc(3y)11.38%
ROICexc(5y)11.15%
ROICexgc(3y)23.06%
ROICexgc(5y)22.82%
ROCE(3y)13.31%
ROCE(5y)13.07%
ROICexgc growth 3Y9.39%
ROICexgc growth 5Y2.67%
ROICexc growth 3Y7.52%
ROICexc growth 5Y3.22%
OM growth 3Y3.77%
OM growth 5Y0.38%
PM growth 3Y2.38%
PM growth 5Y0.71%
GM growth 3Y3.69%
GM growth 5Y0.9%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.62
Debt/EBITDA 0.94
Cap/Depr 94.84%
Cap/Sales 5.76%
Interest Coverage 21.67
Cash Conversion 80.39%
Profit Quality 107.58%
Current Ratio 1.42
Quick Ratio 1.07
Altman-Z 3.94
F-Score7
WACC7.22%
ROIC/WACC1.56
Cap/Depr(3y)105.38%
Cap/Depr(5y)106.63%
Cap/Sales(3y)6.36%
Cap/Sales(5y)6.35%
Profit Quality(3y)93.71%
Profit Quality(5y)90.94%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3Y8.99%
EPS 5Y8.28%
EPS Q2Q%-1.98%
EPS Next Y10.99%
EPS Next 2Y9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.29%
Revenue growth 5Y7.89%
Sales Q2Q%3.51%
Revenue Next Year4.13%
Revenue Next 2Y4.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.7%
EBIT growth 3Y10.29%
EBIT growth 5Y8.3%
EBIT Next Year37.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.41%
FCF growth 3Y16.52%
FCF growth 5Y7.54%
OCF growth 1Y22.61%
OCF growth 3Y9.53%
OCF growth 5Y8.12%

CCL INDUSTRIES INC - CL B / CCL-B.CA Fundamental Analysis FAQ

What is the fundamental rating for CCL-B stock?

ChartMill assigns a fundamental rating of 6 / 10 to CCL-B.CA.


Can you provide the valuation status for CCL INDUSTRIES INC - CL B?

ChartMill assigns a valuation rating of 3 / 10 to CCL INDUSTRIES INC - CL B (CCL-B.CA). This can be considered as Overvalued.


Can you provide the profitability details for CCL INDUSTRIES INC - CL B?

CCL INDUSTRIES INC - CL B (CCL-B.CA) has a profitability rating of 8 / 10.


Can you provide the financial health for CCL-B stock?

The financial health rating of CCL INDUSTRIES INC - CL B (CCL-B.CA) is 7 / 10.


Is the dividend of CCL INDUSTRIES INC - CL B sustainable?

The dividend rating of CCL INDUSTRIES INC - CL B (CCL-B.CA) is 6 / 10 and the dividend payout ratio is 27.88%.